Bispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for ...
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and ...
A gradient boosting model identified MASLD in lean adults with an AUC of 0.779, using 8 routine clinical measurements.
Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...
Pharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity ...
From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care.
Experts at ASN Kidney Week say earlier detection, national CKD screening, and faster uptake are needed to bring new therapies ...
Elagolix 150 mg was noninferior to dienogest 2 mg for reducing moderate-to-severe endometriosis pain in a phase 3 trial of ...
Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap.
Pamala A. Pawloski, PharmD, outlines barriers to precision medicine adoption at AMCP Nexus 2026, calling for standardization ...
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was ...
About half of patients with chronic hepatitis B or C also had MASLD, which tracked with worse fatigue and quality of life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results